TrialBlood advances2026
Bone marrow transplantation for sickle cell disease using posttransplantation cyclophosphamide and 400 cGy TBI.
Marti Goldenberg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it